U.S. Department of Health and Human Services

Iron and Heme Metabolism, Iron Chelation

The Iron and Heme Metabolism, Iron Chelation program supports work on the regulation of iron absorption, utilization, and storage.  Specific areas of interest include: mechanisms underlying disordered iron utilization and sequestration; genetic determinants of inherited and acquired iron overload disorders; heme synthesis, transport, and metabolism; porphyrias; noninvasive measurement of organ and tissue iron load; and iron chelators and chelation therapy.​​​​​​​​​​​


 NIDDK Staff

Terry Rogers Bishop, Ph.D.Hematology; Stem Cells; Hematopoiesis; Globin; Hematology Centers and Training
Cindy N. Roy, Ph.D.Hematology; Iron; Terminal Erythropoiesis


 Related Funding Opportunities

Posted DateTitleFull Announcement
11/20/2015Advancing Erythroid Cell Biology (R01) (Summary) PA-16-039
11/6/2015Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01) (Summary) PAR-16-034
11/6/2015Stimulating Hematology Investigation: New Endeavors (SHINE) (R01) (Summary) PAS-16-033
11/3/2015Innovative Research in HIV in Kidney, Urology, and Hematology (R01) (Summary) RFA-DK-16-015
11/3/2015Studies of HIV in Digestive Diseases Limited to Gastrointestinal Mucosal Immunology and Liver Diseases (R01) (Summary) RFA-DK-16-016
View More Funding Opportunities

The resources listed below include reagents, data, protocols, etc. If you would like to utilize any of these resources, contact the person associated with the resource.


 Research Resources

Resource NameDescription
Evaluating Predictors and Interventions in Sphincter of Oddi Dysfunction

The EPISOD study is a prospective, double-blind, randomized, sham-controlled, multi-center clinical trial. The EPISOD study enrolls subjects who have received a prior cholecystectomy and are diagnosed with the clinical syndrome of Sphincter of Oddi…

Acute Liver Failure Study Group
The Acute Liver Failure Study Group is collecting biosamples and information on the natural history, causes and outcomes of Acute Liver Failure in the United States. In addition to the database, a clinical trial conducted to test whether the drug…
Action to Control Cardiovascular Disease Risk in Diabetes Follow-up Study
ACCORDION (sponsored by NHLBI) is a prospective, observational follow-up study of at least 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.  Treatment in ACCORD ended in 2009 and…
Diabetic Complications Consortium
The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to foster communication and collaboration between investigator communities involved in complications research.  Toward this goal, DiaComp: (1) sponsors annual meetings in…
NIDDK Information Network

The NIDDK Information Network (dkNET), serves the needs of basic and clinical investigators by providing seamless access to large pools of data relevant to the mission of NIDDK. The goal of dkNET is to develop a community-based network for…

View Additional Research Resources


 NIDDK Active Trials in Hematologic Disease

View related clinical trials from ClinicalTrials.gov.


 Related Study Sections


Study sections conduct initial peer review of applications in a designated scientific area. View related study sections from the NIH's Center for Scientific Review.​




HEME-Networks logoIf you’re a researcher in the area of Hematologic diseases, join us on LinkedIn.

NIH Common Fund

Learn about current projects and view funding opportunities sponsored by the​ ​​NIH Common Fund.​